MeMed products

Some infections resolve quickly, while others lead to severe immune dysregulation, respiratory failure and death. Distinguishing between the two is challenging.MeMed COVID-19 Severity builds on an extensive body of evidence supporting the role of viral-induced TRAIL and IP-10 and inflammatory CRP proteins in severe SARS-CoV-2 infection. From a small serum sample, MeMed COVID-19 Severity computationally integrates the levels of these three host immune proteins into a simple score indicating the likelihood of patient deterioration.

A cutting edge multi-purpose immunoassay platform for quantitative diagnostic immunoassays that opens the way to central lab performance at the point-of-need, using chemiluminescence detection technology.

MeMed BV™  is a pioneering blood test to help physicians with the seemingly simple clinical dilemma - does a patient have a bacterial or viral infection.  The test harnesses the power of the world`s most accurate detection system, crafted by nature - the body’s immune system. MeMed BV™ measures and computationally integrates the levels of three immune system proteins: TRAIL, IP-10 and CRP.